SWITCHING FROM PREMIXED INSULIN TO INSULIN GLARGINE-BASED REGIMEN IMPROVES GLYCAEMIC CONTROL IN PATIENTS WITH TYPE 1 OR TYPE 2 DIABETES: A RETROSPECTIVE PRIMARY CARE-BASED ANALYSIS

被引：0
|
作者：
McEwan, P. [1 ]
Gordon, J. P. [1 ]
Sharplin, P. [1 ]
Longman, A. J. [1 ]
Peters, J. [2 ]
Tetlow, A. P. [1 ]
机构：
[1] Cardiff Res Consortium, Cardiff, S Glam, Wales
[2] Cardiff Univ, Cardiff, S Glam, Wales
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66650-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A496 / A496
页数：1
相关论文
共 50 条
  • [31] Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice
    Hammer, H.
    Klinge, A.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (12) : 2009 - 2018
  • [32] Insulin glargine/lixisenatide fixed ratio combination improves glycaemic variability in type 2 diabetes
    Aronson, R.
    Umpierrez, G.
    Stager, W.
    Kovatchev, B.
    DIABETOLOGIA, 2016, 59 : S383 - S383
  • [33] INSULIN GLARGINE UTILIZATION IN REAL-LIFE-EFFICACY OF A REGIMEN BASED ON INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES PREVIOUSLY ON NPH INSULIN IN CLINICAL PRACTICE IN SPAIN
    Delgado, E.
    VALUE IN HEALTH, 2008, 11 (06) : A517 - A517
  • [34] Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus
    Yoshihara, T
    Kumashiro, N
    Kanazawa, Y
    Mita, T
    Sakurai, Y
    Kawai, J
    Abe, M
    Motojima, K
    Hara, K
    Yamazaki, Y
    Kanazawa, A
    Miwa, S
    Sato, F
    Kanno, R
    Shimizu, T
    Sakai, K
    Uchino, H
    Watada, H
    Tanaka, Y
    Kawamori, R
    Hirose, T
    ENDOCRINE JOURNAL, 2006, 53 (01) : 67 - 72
  • [35] Efficacy of insulin glargine in patients with type 1 and 2 diabetes
    Plauschinat, CA
    Cryar, AK
    Godley, PJ
    Nguyen, AB
    Browne, BA
    VALUE IN HEALTH, 2003, 6 (03) : 327 - 328
  • [36] Switching to insulin degludec (IDeg) improves glycaemic control in patients with Type 2 diabetes in a real-world setting
    Feher, M.
    Tentolouris, N.
    Knudsen, S.
    Lapolla, A.
    Prager, R.
    Phan, T. M.
    Wolden, M. L.
    Schultes, B.
    DIABETIC MEDICINE, 2018, 35 : 203 - 203
  • [37] Improved metabolic control in patients with type 1 and type 2 diabetes following the initiation/switching to insulin glargine in clinical practice
    Schreiber, S
    Russmann, A
    DIABETES, 2002, 51 : A114 - A115
  • [38] The outcome of care in people with type 1 and type 2 diabetes following switching to treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis
    Currie, Craig J.
    Poole, Chris D.
    Tetlow, Tony
    Holmes, Paul
    McEwan, Phil
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S33 - S39
  • [39] Linagliptin improves glycaemic control independently of diabetes duration and insulin resistance in patients with type 2 diabetes
    Patel, S.
    Weber, S.
    Emser, A.
    von Eynatten, M.
    Woerle, H. -J.
    DIABETOLOGIA, 2011, 54 : S339 - S339
  • [40] The outcome of care in people with type 1 diabetes after switching to insulin glargine-based regimens in a real-life setting: a long-term observational study
    Dabrowski, M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (08) : 1020 - 1028
12345